Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Convelo Therapeutics Enters Into Collaboration and Option to Acquire Agreement With Genentech to Discover Novel Remyelinating Therapies
Wednesday, July 17, 2019Convelo Therapeutics Inc a biotechnology company with a mission to discover a new class of medicines that regenerate the protective myelin coating around nerve cells has entered into an exclusive worldwide collaboration with Genentech a member of the...
Epistem licence Hubrecht Organoid Technology to expand pre-clinical toxicology service portfolio
Wednesday, July 17, 2019Epistem Limited the UK based preclinical and clinical research services company announces the expansion of its in vitro model portfolio by the completion of an agreement with Hubrecht Organoid Technology HUB to enable the delivery of an increased ran...
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
Tuesday, July 16, 2019AbbVie announced today that it has acquired Seattlebased Mavupharma a privately held biopharmaceutical company focused on novel approaches to target the STING STimulator of INterferon Genes pathway for the treatment of cancer
Hoth Therapeutics, Inc. Expands Working Relationship with the George Washington University and Enters Exclusive License Option Agreement
Tuesday, July 16, 2019Hoth Therapeutics Inc a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitisalso known as eczemaas well as dermatological and chronic wound disorders today announced that...
Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing
Monday, July 15, 2019Sun Pharmaceutical Industries Ltd today announced the US launch of Ezallor Sprinkle rosuvastatin capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing a problem that is estimated to affect appr...
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
Monday, July 15, 2019Gilead Sciences Inc and Galapagos NV announced that they have entered into a year global research and development collaboration Through this agreement Gilead will gain access to an innovative portfolio of compounds including six molecules currently
Ivy Brain Tumor Center and Karyopharm Therapeutics Collaborate to Develop Tissue-Based Clinical Trial for Brain Cancer
Friday, July 12, 2019The Ivy Brain Tumor Center at the Barrow Neurological Institute has announced a partnership with Karyopharm Therapeutics to accelerate the treatment of brain cancer The Ivy Brain Tumor Center will employ Karyopharms firstinclass oral Selective Inhibi...
Forty Seven, Inc. and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement to Develop, Manufacture and Commercialize 5F9
Friday, July 12, 2019Forty Seven Inc a clinicalstage immunooncology company focused on developing therapies to activate macrophages in the fight against cancer and Ono Pharmaceutical Co Ltd today announced an exclusive license agreement for the development manufacture an...
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China
Thursday, July 11, 2019MacroGenics Inc a clinicalstage biopharmaceutical company focused on discovering and developing innovative monoclonal antibodybased therapeutics for the treatment of cancer and IMab Biopharma IMab a China and USbased clinicalstage biopharmaceutical c...
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
Thursday, July 11, 2019Altimmune Inc a clinicalstage biopharmaceutical company today announced that it has entered into an agreement to acquire Spitfire Pharma Inc Spitfire including its product candidate SP to be renamed ALT a potent GLPGlucagon receptor coagonist for the...
